Gane E. Safety and Efficacy at 1 year after Switching from Tenofovir Disoproxil Fumurate to Tenofovir Alafenamide in Chronic HBV Patients with Risk Factors for TDF Use. PS-156.
Remdesivir bij COVID-19: eindresultaten van de WHO Solidarity-studie
aug 2022 | Pneumonie, Virale infecties